Benzinga | Jan 21, 2022 06:20AM EST

Needham Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $155

Needham analyst Mike Matson maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $158 to $155.